Has Matthew Ellis, MD received payments from drug or device companies?

Yes. Drug and device makers reported $51,248 in general payments to Matthew Ellis, MD across 53 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Matthew Ellis, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Matthew Ellis, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Matthew Ellis, MD

Nephrology · Durham, NCNPI 1316048424

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $42,311 of the $51,248 with a category attached, or 82.6%. E.r. Squibb & Sons, L.L.C. accounts for 72.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $46,865 and has fallen 99.5% since, to $246 in 2023. Among nephrology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$51,248in general payments, 2019–2025

Across 53 payments — averaging $966.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

E.r. Squibb & Sons, L.L.C.$37K
Sanofi$10K
Vifor Pharma, Inc.$4K
Boston Scientific$246
Mallinckrodt Hospital Products Inc.$13

What the payments were for

Speaking & faculty fees$42,31183%
Travel & lodging$7,77715%
Food & beverage$1,1472%
Education$130%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
E.r. Squibb & Sons, L.L.C.	35	$37,240
Sanofi	10	$9,621
Vifor Pharma, Inc.	4	$4,128
Boston Scientific	3	$246
Mallinckrodt Hospital Products Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NULOJIX$36,948
THYMOGLOBULIN$9,522
Veltassa$4,000
LithoVue$200

How this compares

$51,248 in reported general payments places this provider in the 95th percentile of 366 nephrology providers in North Carolina.

See all nephrology providers in North Carolina →

Medicare billing

Part B allowed, 2024

$55,147

Medicare patients

238

Services billed

635

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cinacalcet Hcl	47	$23,382
Sirolimus	11	$16,051
Valganciclovir Hcl	43	$8,563
Tacrolimus	41	$4,445
Prednisone	317	$1,951
Atorvastatin Calcium	203	$1,740
Labetalol Hcl	26	$1,442
Mycophenolic AcidMycophenolate Sodium	20	$1,404
Carvedilol	170	$1,400
Mycophenolate Mofetil	26	$1,386
Rosuvastatin Calcium	129	$1,159
Clonidine	14	$1,120
Amlodipine Besylate	226	$963
Calcitriol	43	$905
Pravastatin Sodium	82	$817

Paid to pharmacies, not to this prescriber.

Other nephrology in Durham

John MiddletonDurham$31K
Patrick PunDurham$30K
John MusgroveDurham$9K
Amarnath KathresalDurham$7K
Nora FranceschiniDurham$7K
Daniel EdmonstonDurham$6K
Gregory GreenwoodWinston-Salem$947K
Michael EtomiCharlotte$212K
William KendrickGreenville$125K
Jason EckelCary$123K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →